In the UK, biopharma and biotech sector researcher Porterhouse Insights has appointed Ann-Marie Mulhall as Account Director in its Global Research and Evidence Consultancy.

Launched in 2017 as part of healthcare communications and consultancy services group SCIRIS, Porterhouse applies theoretical principles to exploring the motivations behind behavioural change. The firm uses tools and technologies to design 'real world' research solutions for clients, with the aim of optimizing the decision-making process across the product lifecycle.

Mulhall (pictured) joins with seven years' healthcare research agency experience, having previously been an Account Director at Lumanity (formerly Cello Health); Qualitative and Quantitative Researcher at the Research Partnership; and KOL Research Project Manager at WPP-owned System Analytic (now part of VMLY&R Health). Early in her career, she was a Clinical Data Scientist at GSK.

Head of Insights David Eatwell comments: 'Ann-Marie brings a valuable set of research acumen to our growing team, helping us to tread new ground and explore new client relationships, at the same time as helping to build who we are as a company and what we represent for our clients'.

Web site: www.porterhouseinsights.com .

• Printer-friendly version of this article.
• Email this article to a friend.